Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
Infographics
News analysis
Pricing snapshots
Brand price trackers
Flavour trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United States FDA cracks the whip over illegal sales of popular disposables…
  • World WHO calls for ending subsidies for tobacco farming…
  • Europe Commissioner releases statement on World No Tobacco Day…
  • Denmark Tax Agency seizes non-compliant disposable vapes…
  • Ireland Cabinet approves vaping bill…
  • Germany BVL updates the notified e-cig product list…
  • United Kingdom Enforcement measures for under-age vaping set to increase…
  • Ukraine Advertising Act amendment bill adopted…
  • Czech Republic Today is the deadline for submitting e-cig market information..
  • Czech Republic Tobacco survey results published for World No Tobacco Day…
  • Kuwait Calls for increased tobacco taxation to reduce consumption…
  • Israel Health ministry publishes anti-vaping leaflet…
View all
News analysis

Reynolds asks FDA to give Camel Snus products ‘modified risk’ status

Written by || 19th December 2017 || News analysis || Companies | Marketing and Retailing | Regulation and Legislation | North America United States

R. J. Reynolds has submitted modified risk tobacco product applications (MRTPAs) to the US FDA for six forms of its Camel Snus product, which it is seeking to market as reducing the risk of specific smoking-related diseases ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA rejects snus as modified risk – but could reconsider some aspects
PMTA and MRTP: navigating the path to FDA approval for reduced-risk products
The way ahead: Big Tobacco looks to a smoke-free next generation